Observing Blood Changes in Cancer Patients During Chemotherapy
NCT00034216 · RecruitingThis study collects blood from patients with cancer to learn more about cells that affect the immune system. Researchers want to see how these cells change before and after chemotherapy. Patients aged 18 and older can join. This study does not involve any treatment.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- National Institutes of Health Clinical CenterBethesda, MarylandRecruiting
Who can join
This trial is open to adults aged 18 and older, including both patients with cancer and healthy volunteers. Participants must understand the study and be willing to sign a consent form. The trial team will confirm eligibility.
What happens during the trial
Participants will have about 50 ml of blood drawn. There are two groups: one for healthy volunteers and another for patients with cancer. Blood samples may also be taken again during treatment if needed.
The trial team
The trial is sponsored by the National Cancer Institute (NCI). The principal investigator is Dr. Jennifer L Marte from the NCI.
Important dates
The trial started on July 16, 2002, and is currently recruiting new participants. It is expected to finish by June 1, 2026.
Additional information
This is trial NCT00034216. It is not looking at a specific treatment but aims to understand how certain cells work in cancer. About 1,750 participants are expected to join.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →